CTTHStock

CTT PHARMACEUTICAL HOLDINGS, INC.

About CTT PHARMACEUTICAL HOLDINGS, INC.

CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) is a US-listed equity tracked across major market indices. CTT PHARMACEUTICAL HLDGS

The company reports net loss of $341,930. Key metrics include a return on equity of -46.3%, a debt-to-equity ratio of 0.25.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for CTTH to support both active traders and long-term investors.

Fundamentals

Revenue (TTM)
Net Income (TTM)$-341,930
EPS (TTM)
P/E Ratio
Return on Equity-46.33%
Debt-to-Equity0.25
Dividend per Share

Want real-time analysis on CTTH?

Track it free in your trading journal. Log trades, tag setups, and review your edge.

Get started